Phargest SA
7.8 FTEThe score of Phargest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets +13 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phargest's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 57,206 € | ||||
| Equity | 871,154 € | ||||
| Cash | 233,280 € | ||||
| EBITDA | 208,768 € | ||||
| Total assets | €1.78m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Phargest's financial analysis
- Solvency48.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phargest
Phargest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.558.574
- VAT number
- BE0449558574
- Peppol
- Registered · 0208:0449558574 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 04 Mar 1993
- Registered office
- 5170 Profondeville
- Size
- Micro · 7.8 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phargest (SA) has been based in Profondeville since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 57,206 € and equity of 871,154 €; its revenue is not published. With 7.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.9%, above the median of its sector (41.5%).
Companies similar to Phargest
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Farmagora Retail sale of pharmaceutical products Ternat · balance sheet €1.78m
- Pharmacie DU Laveu Retail sale of pharmaceutical products Liège · balance sheet €1.78m
- Apotheek Dirk VAN Herck Retail sale of pharmaceutical products Nijlen · balance sheet €1.77m
- D4-Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet €1.77m
- Bytebier Kaatje Retail sale of pharmaceutical products Boechout · balance sheet €1.80m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
Frequently asked questions about Phargest
What is the revenue of Phargest?
Phargest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phargest?
In Belgium, the VAT number is the company number prefixed with BE: BE0449558574 for Phargest, if the company is VAT-registered. Its company number (CBE) is 0449.558.574.
Where is the registered office of Phargest?
According to the CBE register, the registered office of Phargest is in 5170 Profondeville.
What is the equity of Phargest?
At the close of the 2025 financial year, the equity of Phargest amounts to 871,154 €, a solvency of 48.9% of total assets.
How many people work at Phargest?
7.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phargest?
The register lists 3 active mandates at Phargest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phargest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →